Skip to main content

Table 4 Analysis of the effect sizes (Cohen’s d), expressed as the mean (95% CI) and p value, for differences in adjusted means between the groups after the intervention

From: Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study

 

Lower VS control

Medium VS control

High VS control

Medium VS Lower

High VS Lower

High VS Medium

ES (95%CI)

P value

ES (95%CI)

P value

ES (95%CI)

P value

ES (95%CI)

P value

ES (95%CI)

P value

ES (95%CI)

P value

VO2@VT1

0.61

0.16

1.45

<0.01

2.62

<0.01

0.83

0.05

2.03

<0.01

1.20

0.01

(L/min)

-0.25,1.42

0.48,2.30

1.43,3.62

-0.03,1.63

0.99,2.93

0.30,2.03

%VO2max@VT1

0.34

0.42

0.89

0.04

1.56

0.01

0.55

0.19

1.22

0.01

0.69

0.10

(%)

-0.50,1.15

0.00,1.71

0.58,2.45

-0.28,1.34

0.31,2.04

-0.16,1.49

HR@VT1

0.1

0.81

0.86

0.05

1.19

0.01

0.72

0.09

1.06

0.02

0.36

0.38

(bpm)

-0.72,0.92

-0.02,1.68

0.26,2.03

-0.13,1.52

0.17,1.87

-0.46,1.15

Power @VT1

0.56

0.18

1.15

0.01

2.30

<0.01

0.58

0.16

1.74

<0.01

1.17

0.01

(Mets)

-0.29,1.38

0.23,1.99

1.18,3.25

-0.25,1.38

0.75,2.61

0.27,1.99

Power @VT2

0.99

0.02

0.77

0.07

1.25

0.01

0.22

0.59

0.26

0.52

0.48

0.24

(Mets)

0.09,1.82

-0.10,1.59

0.32,2.09

-0.59,1.01

-0.55,1.05

-0.35,1.27

  1. bpm beat per minute